ANDA 85213, held by Sandoz. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 85213 (Hydro-Serp "50"), held by Sandoz, was first approved by FDA on Apr 16, 1981, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 16, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydro-Serp "50"50MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters